Is There a Typical COVID-19 Rash?
There is no single, distinctive appearance that identifies a COVID-19-associated rash. Reported skin eruptions associated with the virus present in a wide variety of forms, making visual identification alone insufficient for diagnosis. The American Academy of Dermatology Association notes that these eruptions can appear as patchy rashes, itchy bumps or hives, chickenpox-like blisters, pinpoint spots, large patches with smaller ones, lacy patterns, and areas where flat spots and raised bumps merge.
Because of this wide variation in appearance, neither the look of the rash nor its duration can confirm that COVID-19 caused it. Many other conditions produce similar skin changes. Allergic reactions, shingles, overheating, other infections, and medication reactions are common alternative causes.
Descriptions of rash color must also account for differences in skin tone. While redness is frequently described in lighter skin, darker skin tones may show purplish swelling, brownish-purple spots, or other discolorations that do not present as bright red. Because the visual features overlap significantly with other dermatological conditions, relying on appearance to diagnose a rash is unreliable. Clinical evaluation, including consideration of recent symptoms or test results, is necessary to determine the underlying cause.
Common COVID-19-Associated Rash Patterns
COVID-19-associated skin findings manifest in several distinct patterns, each with observable features that vary in texture, spread, and sensation. Understanding these patterns helps in describing the condition to a clinician, though none are diagnostic on their own.
Measles-like or morbilliform eruptions often present as flat, red patches that may merge together, sometimes accompanied by smaller raised bumps. Hives appear as raised, itchy welts that can vary in size and shape, often moving across the body. Small blister-like eruptions resemble chickenpox, featuring fluid-filled lesions that may crust over. Pinpoint spots are tiny, distinct red or purple dots that do not blanch when pressed.
Other reported patterns include larger patches of discoloration surrounded by smaller spots, as well as lacy or net-like discoloration. Lesions may be localized to specific areas or widespread across the body. Sensations associated with these rashes range from intense itching to pain or tenderness, though some individuals may experience little to no discomfort.
Oral sores and rare vascular-looking discolorations have also been reported, but these are less common and should not be considered expected symptoms. The key distinction across all these patterns is that they are non-specific. A measles-like rash, for example, is far more commonly caused by other viral infections or drug reactions than by SARS-CoV-2. The presence of any of these patterns requires further clinical context to determine their origin.
How COVID Toes Look and Feel
COVID toes, clinically referred to as chilblain-like lesions, involve swelling and discoloration of one or more toes, though fingers can also be affected, either alone or together with the toes. The affected areas may appear pink, red, purple, reddish-brown, or brownish-purple. These lesions can itch or hurt, and may develop spots, raised rough areas, or blisters.
The appearance of these lesions varies by skin tone. In lighter skin, the initial presentation may be bright redness that transitions to purple. In darker skin, the signs may manifest as purplish swelling or brownish-purple spots, which can be harder to distinguish without close examination. The discoloration may evolve over time, and the lesions can be tender to touch.
Despite the name, researchers continue to investigate whether SARS-CoV-2 directly causes these lesions. Many young people who developed these symptoms felt well and tested negative for the virus. The presence of these toe lesions cannot be treated as proof of infection. They resemble chilblains, which can be triggered by cold exposure or other factors. Because the causal relationship remains uncertain, these lesions should be evaluated in the context of other symptoms and exposures rather than assumed to indicate COVID-19.
Where and When the Rash May Appear
Reported COVID-19-associated rashes can occur on many different body areas, including the legs, arms, torso, and hands. They may appear during an active infection or after the illness has resolved. There is no single body site or sequence of appearance that is definitive for COVID-19. Rashes have been documented in various locations, reflecting the systemic nature of the inflammatory response, but their location does not confirm the diagnosis.
The timing and duration of these skin findings also vary. Most reported COVID-19-associated rashes appear to last between 2 and 12 days. Toe lesions may last substantially longer, often persisting for several weeks. Some individuals have reported persistent skin symptoms that continue long after other signs of infection have resolved, a phenomenon observed in the context of long COVID.
These duration ranges are observational and not diagnostic rules. A rash that lasts longer than two weeks does not necessarily indicate long COVID, nor does one that resolves quickly rule out a viral cause. Other conditions, such as allergic reactions or drug eruptions, can have similar timelines. The persistence or timing of a rash should be considered alongside other clinical factors rather than used as a standalone indicator.
Symptoms That May Occur Alongside the Rash
A rash associated with COVID-19 may occur alongside other symptoms commonly linked to the virus, such as fever, cough, shortness of breath, fatigue, and muscle aches. A rash can also appear without these usual respiratory symptoms, and its presence alone is not specific enough to diagnose COVID-19. Many people with mild or asymptomatic COVID-19 may develop skin changes as one of the few visible signs of infection.
Distinguish an ordinary isolated rash from the rare but serious condition known as multisystem inflammatory syndrome (MIS). MIS can occur after COVID-19 and involves a combination of systemic symptoms. While a rash may be one component of MIS, it is the constellation of other symptoms that raises concern. These warning features include fever lasting for days, abdominal pain, vomiting, diarrhea, bloodshot eyes, dizziness, swollen neck glands, confusion, difficulty staying awake, cracked discolored lips, swollen discolored hands or feet, or a swollen strawberry-like tongue.
When a rash occurs with these multisystem symptoms, it requires immediate medical attention. An isolated rash with mild or no other symptoms is generally less urgent but still warrants evaluation if it is severe, painful, or persistent. Understanding the accompanying symptoms helps clinicians differentiate between a common viral rash, an allergic reaction, and a more serious systemic condition.
COVID-19 Rash or Another Skin Condition?
Differentiating a COVID-19 rash from other skin conditions can be challenging because many dermatological issues present with similar features. Allergic reactions, medication eruptions, overheating, shingles, chilblains, hives, chickenpox-like illnesses, and other infections can all resemble reported COVID-19 skin findings. For instance, hives are common in drug allergies and viral infections alike, while blisters can indicate chickenpox, shingles, or contact dermatitis.
Because of this overlap, timing, exposures, new medicines, and other symptoms matter more than resemblance alone. If a person develops a rash shortly after starting a new medication, a drug reaction is a strong possibility. If the rash appears after exposure to cold weather, chilblains are more likely. If other family members have similar symptoms, an infectious cause is probable.
Clinicians recommend COVID-19 testing when a person develops a rash or other COVID-19 symptoms, such as fever, cough, shortness of breath, fatigue, or muscle aches. Inform the dermatologist or primary care provider about any positive test results or recent symptoms. Labeling an unexplained rash as COVID-19 solely based on its appearance is not accurate. Testing and clinician assessment are the only reliable ways to clarify the cause, as visual inspection alone cannot confirm or exclude SARS-CoV-2 infection.
When to Contact a Clinician or Seek Immediate Care
Individuals with a concerning or unexplained rash should contact a clinician or dermatologist for evaluation. Reporting any associated COVID-19 symptoms or a positive test result helps the provider determine the appropriate course of action. In some cases, a remote consultation may be sufficient, but an in-person examination is often necessary for accurate diagnosis.
For swollen, discolored toes or fingers, prompt medical assessment is advised if the skin does not improve within 2 to 3 weeks. Additional reasons to seek care include if the blue or purple discoloration darkens or spreads up a limb, or if numbness, blisters, sores, pus, fever, or chills develop. These signs may indicate a secondary infection or a more serious underlying vascular issue.
Immediate medical care is critical if a person experiences the warning signs of multisystem inflammatory syndrome. This includes fever lasting for days accompanied by abdominal pain, vomiting, diarrhea, bloodshot eyes, dizziness, swollen neck glands, confusion, difficulty staying awake, rash, cracked discolored lips, swollen discolored hands or feet, or a swollen strawberry-like tongue. This condition is rare but serious and requires urgent intervention.
Do not attempt to self-treat with prescription medications, doses, anticoagulants, or corticosteroids without medical guidance. Treatment depends entirely on the diagnosis and severity of the condition. Always consult a healthcare professional for personalized advice and appropriate management.